FNY Investment Advisers’s Avidity Biosciences RNAM Stock Holding History

FNY Investment Advisers’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,976	Closed	-$3.68M	–	1042
2025 Q4	$3.68M	Buy	50,976 +43,382	+571%	+$2.8M	1.04%	16
2025 Q3	$330K	Buy	+7,594	New	+$307K	0.11%	203
2020 Q3	–	Sell	-500	Closed	-$14K	–	588
2020 Q2	$14K	Buy	+500	New	+$14.4K	0.01%	262

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

FNY Investment Advisers's RNAM Position: Q1 2026 in Review

FNY Investment Advisers sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 50,976 shares — an estimated $3.68M sold.

FNY Investment Advisers first reported a position in RNAM in Q2 2020 and held it in 3 quarters. The position peaked at $3.68M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

FNY Investment Advisers reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
FNY Investment Advisers sold 50,976 Avidity Biosciences shares in Q1 2026, an estimated $3.68M.
FNY Investment Advisers first reported a position in Avidity Biosciences in Q2 2020 and held it in 3 quarters.
FNY Investment Advisers's Avidity Biosciences position peaked at $3.68M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on FNY Investment Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.